Kaiser Permanente does cover transcranial magnetic stimulation, but coverage is conditional. The answer to “does Kaiser cover TMS” is yes for adults with treatment-resistant major depressive disorder who meet Kaiser’s clinical criteria and get prior authorization first. Coverage for other diagnoses, for Medicare members, and across Kaiser’s regional health plans is less uniform. To confirm what your specific plan includes, check your Evidence of Coverage or call Member Services at 1-888-901-4636.
What Kaiser Covers TMS For
The core approved use is major depressive disorder that hasn’t responded to medication. Kaiser’s own depression guideline defines treatment-resistant depression as depression that “fails to respond to treatment despite multiple trials of at least two different antidepressants.”1Kaiser Permanente Washington Provider. Clinical Practice Guidelines: Depression FDA-cleared TMS devices are indicated for adults who have failed at least one antidepressant at an adequate dose and duration.2Kaiser Permanente Washington Provider. Clinical Review Criteria: Transcranial Magnetic Stimulation
For non-Medicare members, Kaiser reviews requests against proprietary MCG Care Guidelines (document MCG B-KP-801-T), with the current version effective August 1, 2024.3Kaiser Permanente Washington Provider. Clinical Review Criteria: Transcranial Magnetic Stimulation Because MCG is proprietary, Kaiser does not publish the exact checklist, but members and providers can request a copy of the criteria being applied to a specific case by calling Clinical Review at 1-800-289-1363.2Kaiser Permanente Washington Provider. Clinical Review Criteria: Transcranial Magnetic Stimulation
For Medicare members, Kaiser follows CMS rules, specifically Local Coverage Determination L37086 and Local Coverage Article A57692.3Kaiser Permanente Washington Provider. Clinical Review Criteria: Transcranial Magnetic Stimulation Under that LCD, TMS is considered reasonable and necessary for adults with severe major depressive disorder who have either failed trials of medications from two different drug classes or could not tolerate them. A trial of evidence-based psychotherapy is also required, and the treatment must be ordered by a psychiatrist with TMS experience.4CMS Medicare Coverage Database. Transcranial Magnetic Stimulation (TMS), LCD L37086 The same LCD classifies ongoing maintenance TMS as experimental and investigational, so it is not covered under Medicare. Retreatment after a relapse may be covered if the patient previously met initiation criteria and achieved more than 50% improvement on a standard depression rating scale.5CMS Medicare Coverage Database. Billing and Coding: Transcranial Magnetic Stimulation (TMS), A57692
The minimum age in Kaiser’s current policy history is 18. A Washington medical technology review in October 2025 called TMS for adolescent depression “promising” but downgraded the certainty of the evidence, and the age floor was not expanded.3Kaiser Permanente Washington Provider. Clinical Review Criteria: Transcranial Magnetic Stimulation
Your Region Matters
Kaiser Permanente is not a single national insurer. It operates through regional health plans with their own governance and review committees. The clinical criteria published for Washington explicitly state they “only apply to Kaiser Foundation Health Plan of Washington and Kaiser Foundation Health Plan of Washington Options, Inc.”3Kaiser Permanente Washington Provider. Clinical Review Criteria: Transcranial Magnetic Stimulation A coverage decision in one Kaiser region does not predict what will happen in another.
Practice shows real variation. The Mid-Atlantic Permanente Medical Group has integrated TMS directly into its behavioral health services.6Kaiser Permanente Mid-Atlantic. Magnetic Stimulation Offers MAPMG New Alternative for Depression In Southern California, at least one external TMS clinic operates as an in-network Kaiser provider. The Washington region’s technology committee, by contrast, has historically cited “insufficient evidence” on long-term outcomes.2Kaiser Permanente Washington Provider. Clinical Review Criteria: Transcranial Magnetic Stimulation
What About Conditions Other Than Depression?
Kaiser’s TMS criteria are built around depression. Any other diagnosis routes to an individual Medical Director Review rather than routine coverage.3Kaiser Permanente Washington Provider. Clinical Review Criteria: Transcranial Magnetic Stimulation TMS devices have received FDA clearance for obsessive-compulsive disorder, but Kaiser’s internal documentation does not contain a specific approval for that use, and the clinical trials Kaiser’s technology assessments drew on excluded OCD patients.2Kaiser Permanente Washington Provider. Clinical Review Criteria: Transcranial Magnetic Stimulation For Medicare members, the applicable LCD specifically classifies TMS for OCD as experimental and investigational.4CMS Medicare Coverage Database. Transcranial Magnetic Stimulation (TMS), LCD L37086
Kaiser’s own health encyclopedia notes that TMS “may help” with anxiety, PTSD, OCD, chronic pain, and migraines, but attaches a disclaimer that not all treatments described are covered benefits.7Kaiser Permanente Health Encyclopedia. Transcranial Magnetic Stimulation (TMS) Accelerated protocols such as Stanford’s SAINT are not addressed in Kaiser’s published criteria.
Prior Authorization and Referrals
Kaiser requires prior authorization for TMS. Providers can verify authorization requirements for the relevant procedure codes (90867, 90868, and 90869) through Kaiser’s Pre-authorization Code Check tool on the provider portal. Even a psychiatric evaluation performed to determine TMS candidacy is reviewed against the same TMS clinical criteria.2Kaiser Permanente Washington Provider. Clinical Review Criteria: Transcranial Magnetic Stimulation
The referral path varies by region. In the Mid-Atlantic, a patient who meets criteria for a major depressive episode is first referred by a behavioral health nurse to a psychiatrist. The psychiatrist evaluates TMS candidacy and, if appropriate, submits a referral to the regional TMS lead through Kaiser’s electronic health record using a standardized template, with appointments scheduled via the eConsult system.6Kaiser Permanente Mid-Atlantic. Magnetic Stimulation Offers MAPMG New Alternative for Depression
What TMS Will Cost You
Cost-sharing depends on the plan. One concrete example: the 2026 Kaiser Gold 80 HMO plan in California lists TMS at $40 per visit with no deductible, and the cost counts toward the plan’s out-of-pocket maximum.8Kaiser Permanente. Evidence of Coverage: Gold 80 HMO A full course usually runs 20 to 36 sessions, so copays accumulate. Check your Evidence of Coverage for exact amounts.
If Kaiser Denies Coverage
You have structured appeal rights, and Kaiser must provide you a free copy of the clinical guidelines used in the denial.9Kaiser Permanente Washington Provider. Appeals
- Standard internal appeal. Non-Medicare members can appeal orally or in writing, typically resolved in 14 to 30 days. Medicare Advantage appeals must be in writing and are resolved within 7 to 60 days depending on the service.
- Expedited appeal. Available when the standard timeline could jeopardize your health. Kaiser must respond within 72 hours, and a treating provider can request one on your behalf without a formal representative form.
- External review. Medicare Advantage cases are automatically sent for external review if the internal appeal is denied. Commercial members have 180 days from the internal decision to request external review.
Federal Employee Health Benefits members have an additional step: after Kaiser’s final decision, they can ask the Office of Personnel Management to review, with a decision issued within 60 days.10Kaiser Permanente. FEHB Appeals and Disputed Claims Fact Sheet
When TMS Is Not an Option Regardless of Coverage
Even an approved authorization will not override medical contraindications. Kaiser’s clinical documents list absolute contraindications: metallic or ferromagnetic objects in the head or eye, cochlear implants, and implanted pacemakers or similar devices. Relative contraindications include a history of seizures, skull trauma, cerebral damage, severe migraines, hearing loss, substance abuse, pregnancy, and severe heart disease.2Kaiser Permanente Washington Provider. Clinical Review Criteria: Transcranial Magnetic Stimulation These align with FDA and Medicare safety profiles.11CMS Medicare Coverage Database. Transcranial Magnetic Stimulation (TMS), LCD L34998 If any of these apply to you, raise them with your psychiatrist before the authorization process begins.